Last €200.77 EUR
Change Today -4.89 / -2.38%
Volume 524.0
RGO On Other Exchanges
Symbol
Exchange
Munich
As of 12:36 PM 05/21/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Murray A. Goldberg

Chief Financial Officer, Senior Vice President of Finance & Administration and Assistant Secretary, Regeneron Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

67$9,623,067
As of Fiscal Year 2012

Background*

Mr. Murray A. Goldberg has been the Chief Financial Officer and Senior Vice President of Finance & Administration at Regeneron Pharmaceuticals, Inc. since March 1995 and December 2000 respectively and its Assistant Secretary January 2000. Mr. Goldberg served as Vice President of Finance and Administration and Treasurer at Regeneron Pharmaceuticals, Inc. since March 1995. Prior to joining Regeneron Pharmaceuticals Inc., Mr. Goldberg served as Vice President of Finance, ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-347-7000
Fax: 914-347-2113

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MBA
The University of Chicago
MS
The London School of Economics and Political Science

Other Affiliations*

Annual Compensation*

Salary$464,500
Bonus$367,884
Total Annual Compensation$832,384

Stock Options*

All Other Compensation$30,198
Exercised Options206,500
Exercised Options Value$17,799,976
Exercisable Options227,818
Exercisable Options Value$31,074,825
Unexercisable Options263,875
Unexercisable Options Value$23,353,363
Total Value of Options$72,228,163
Total Number of Options698,193

Total Compensation*

Total Annual Cash Compensation$862,582
Total Short Term Compensation$832,384
Other Long Term Compensation$30,198
Total Calculated Compensation$9,623,067
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGO:GR €200.77 EUR -4.89

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman and Chief Executive Officer
Alkermes plc
$775.0K
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$821.1K
N. Anthony Coles M.D., M.P.H.Chairman, Chief Executive Officer and President
Onyx Pharmaceuticals, Inc.
$740.0K
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
David E. I. Pyott Chairman, Chief Executive Officer and President
Allergan Inc.
$1.3M
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.